spacer
home > pmps > winter 2018 > every drop counts
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Every Drop Counts

Drugs based on blood plasma or other biological microorganisms are – in comparison to chemical-based materials – expensive in their extraction. It is equally costly and complex to process these products to obtain a safe API. Even the smallest quantities represent high financial value. All processes, in particular filling and closing, and the upstream and downstream functions must be designed to generate the maximum output of pharmaceuticals from an existing product quantity.

The biopharmaceutical market is continually growing. These drugs might have the greatest potential to solve the medical challenges of the near future, such as multi-resistant germs and rare diseases.

To meet the special requirements of these expensive pharmaceuticals, the entire filling and packaging process has been analysed and revised. During this, waste caused by underfilling should be avoided, as should overfilling. If the overfill fluctuates within a defined tolerance, expensive product is involuntarily ‘given away’. On the other hand, if the fill volume is outside the tolerance, the container must be rejected. Many other factors in the manufacturing process have a significant impact on the maximised product yield, according to the experts at the Schwäbisch Hall company. These factors are explained in more detail later.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Matthias Poslovski, a graduate mechanical engineer, has been with the Optima Group since 1998. He began his career with the company as Sales Manager of the former division Inova pharma systems. From 2000 to 2002, Matthias managed the Optima division of Kugler; its expertise was in non-sterile filling and packaging technology. Today, he holds the title of Director Technical Sales at Optima Pharma. His responsibilities encompass the overall support of sales worldwide. 
spacer
Matthias Poslovski
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

PHARM Connect 2019

Life science and business are going to meet at PHARM Connect on the 12-13 of March 2019 in Budapest, Hungary to continue the tradition of providing high calibre, customised professional partnering opportunities for pharma and biotech professionals from Central & Eastern European and beyond and deliver the crucial information they need to excel in their work. The influential annual gathering brings together over 400 global and regional decision-makers, top scientists, industry executives and business development leaders for the ninth time to identify new business opportunities, technologies, state-of-the-art formulation development strategies and to foster exchange of ideas on the role of the sector.
More info >>

White Papers
 
Industry Events

DIA 2019 Global Annual Meeting

23-27 June 2019, San Diego Convention Center

DIA 2019 is more than just a meeting: it’s where brilliant minds come together to create solutions. Thousands of global innovators will convene to engage in discussions on today’s hottest topics in the life sciences field, propose ways to combat daily challenges, and network to create lasting connections.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement